Raphael E. Szalat
Impact in
- Hematology top 0.5%
- Multiple Myeloma Research and Treatments
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 45
- Multiple Myeloma Research and Treatments 42
-
- Amyloidosis: Diagnosis, Treatment, Outcomes 15
- Protein Degradation and Inhibitors 14
- Cancer therapeutics and mechanisms 7
- Co-authors
- Nikhil Vilas Munshi (19 shared papers)Hervé Avet‐Loiseau (16 shared papers)Nikhil C. Munshi (11 shared papers)Mehmet Samur (20 shared papers)Kenneth Carl Anderson (13 shared papers)Marion Malphettes (9 shared papers)Bouchra Asli (7 shared papers)Mariateresa Fulciniti (12 shared papers)
- Journals
- Blood (17 papers)Leukemia (6 papers)Blood Advances (4 papers)American Journal of Hematology (4 papers)Nature Communications (4 papers)
- Partner nations
- United StatesFranceItaly
In The Last Decade
Raphael E. Szalat
68 papers receiving 2.6k citations
Raphael E. Szalat's Hit Papers
Peers
Comparison fields: 5 of 81
- Hematology 1.6k
- Genetics 313
- Oncology 676
- Molecular Biology 1.5k
- Cancer Research 251
Countries citing papers authored by Raphael E. Szalat
This map shows the geographic impact of Raphael E. Szalat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raphael E. Szalat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raphael E. Szalat more than expected).
Fields of papers citing papers by Raphael E. Szalat
This network shows the impact of papers produced by Raphael E. Szalat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raphael E. Szalat. The network helps show where Raphael E. Szalat may publish in the future.
Co-authors
The 25 scholars most cited alongside Raphael E. Szalat, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 74 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 376 | |
| 2 | A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis Hit paper breakdown → | 2018 | 364 |
| 3 | 2019 | 218 | |
| 4 | 2018 | 174 | |
| 5 | 2015 | 96 | |
| 6 | 2017 | 92 | |
| 7 | 2014 | 84 | |
| 8 | 2020 | 80 | |
| 9 | 2011 | 74 | |
| 10 | 2015 | 69 | |
| 11 | 2022 | 58 | |
| 12 | 2016 | 53 | |
| 13 | 2020 | 52 | |
| 14 | 2016 | 48 | |
| 15 | 2013 | 48 | |
| 16 | 2017 | 47 | |
| 17 | 2018 | 46 | |
| 18 | 2017 | 39 | |
| 19 | 2014 | 35 | |
| 20 | 2023 | 34 |
About Raphael E. Szalat
Raphael E. Szalat is a scholar working on Hematology, Molecular Biology, Genetics, Oncology and Cancer Research, having authored 74 papers that have together received 2.6k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (42 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (15 papers), Protein Degradation and Inhibitors (14 papers), Chronic Lymphocytic Leukemia Research (7 papers), Cancer therapeutics and mechanisms (7 papers), Peptidase Inhibition and Analysis (6 papers), Cancer Genomics and Diagnostics (5 papers) and Histiocytic Disorders and Treatments (4 papers). The work is most often cited by research in Hematology (1.6k citations), Genetics (313 citations), Oncology (676 citations), Molecular Biology (1.5k citations) and Cancer Research (251 citations). Raphael E. Szalat has collaborated with scholars based in United States, France and Italy. Frequent co-authors include Nikhil Vilas Munshi, Hervé Avet‐Loiseau, Nikhil C. Munshi, Mehmet Samur, Kenneth Carl Anderson, Marion Malphettes, Bouchra Asli, Mariateresa Fulciniti, Bertrand Arnulf and Lionel Galicier. Their work appears in journals such as Blood, Leukemia, Blood Advances, American Journal of Hematology and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.